ORASURE TECHNOLOGIES

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

08 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

03 ноя 2022 09:15:00 Источник Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store

02 ноя 2022 07:05:00 Источник Nasdaq GlobeNewswire

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET

01 ноя 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

28 сен 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

20 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

14 сен 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

09 авг 2022 16:05:02 Источник Nasdaq GlobeNewswire

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

02 авг 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

28 июл 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

14 июл 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 июн 2022 16:05:00 Источник Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

25 май 2022 07:05:00 Источник Nasdaq GlobeNewswire

Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

23 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

17 май 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

10 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

03 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

07 апр 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

31 мар 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

22 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire